Impact of COVID-19 on Pharmaceutical Social Media Influencer Activity – June 2020
- Pages: 90
- Published: June 2020
- Report Code: GDHCHT134
The highly contagious coronavirus (SARS-CoV-2), dubbed COVID-19 (formerly 2019-nCoV), which emerged at the close of 2019, has led to a medical emergency across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020. This report analyzes GlobalData’s social media Influencer dashboards to understand Influencer trends since the pandemic began and what key Influencers are discussing online about COVID-19.
This report analyzes Influencer trends since the pandemic began and what assesses what key Influencers are discussing online about the virus.
The report includes 10 Influencer dashboards:
•Eight therapy areas: Cardiovascular, Metabolic Disorders, Immunology, Infectious Diseases, Neurology, Oncology, Ophthalmology, and Biosimilars
This report will be updated every month.
This report analyses May 2020 activity, with April included as a comparison.
Reasons to buy
• View Influencer trends across different therapy areas and themes since the COVID-19 pandemic began.
• Stay up to date on what key Influencers are discussing online about the virus.
• Identify key Influencers across therapy areas and themes.
Table of Contents
Impact of COVID-19 on Social Media Influencers
− Metabolic Disorders
− Infectious Diseases
− Digital Pharma
− Macroeconomic Influencers
− Related Reports
− About the Authors
− About GlobalData